FDA & COVID: US Clinical Studies & Market Access Discussion - McDermott Skip to main content

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Overview


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.

Dig Deeper

Miami, FL / In-person / March 4-5, 2026

HPE Miami 2026

Las Vegas, NV and Virtual / Speaking Engagements / February 11 – 13, 2026

AHLA Winter Institute 2026: Advising Providers and AI in Health Care

San Francisco, CA / In-person / January 13, 2026

McDermott Forum at the 2026 J.P. Morgan Healthcare Conference

Dallas, TX / In-person / November 20, 2025

BIO BREAK: Dallas’ Monthly Life Sciences Happy Hour

Webinar / Speaking Engagements / November 20, 2025

From Data to Delivery: The New Healthcare Continuum